CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel Cohort Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of Intravenously Infused BIIB092 in Patients With Four Different Primary Tauopathy Syndromes

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03658135
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:28.230454+00:00
Published At: 2019-12-19T00:00:00+00:00
Record Updated At: 2019-12-19
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Primary Tauopathies", "Corticobasal Degeneration Syndrome", "Frontotemporal Lobar Degeneration With Tau Inclusions", "MAPT Mutation Carriers, Symptomatic", "Traumatic Encephalopathy Syndrome", "Nonfluent Aphasia, Progressive"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2019-12-19"
protocolSection.identificationModule.nctId: "NCT03658135"
protocolSection.identificationModule.officialTitle: "A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel Cohort Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of Intravenously Infused BIIB092 in Patients With Four Different Primary Tauopathy Syndromes"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.